Work

Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia

Year: 2017

Type: article

Source: Nature Medicine

DOI: 10.1038/nm.4310

Authors: Meenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, Erika Huber, Sara Rohrabaugh, Zain Siddiqui, Muhammad F Bouso, Tahir Latif, Ming Xu, Kakajan Komurov, James C Mulloy, Jose A Cancelas, H Leighton Grimes, Mohammad Azam

Institutions: Cincinnati Children's Hospital Medical Center, University of Cincinnati, University of Chicago

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: V Foundation for Cancer Research, Leukemia Research Foundation, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Mechanisms of drug resistance in Myeloproliferative neoplasms treated with JAK2 i, Improved therapeutic approaches for hematological disorder treated with tyrosine

OpenAlex ID: W2603057731

FWCI: 7.363

Cites: 61

Cited by: 101

Related to: 10